Danielle Thomas, MD
Orthopaedic Surgery · Santa Barbara, CANPI 1164808127
Payments from drug & device makers
Across 97 payments — averaging $76.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Micromed Inc$2K
- Pacira Therapeutics, Inc.$512
- Bioventus LLC$426
- Smith+Nephew$208
- Pylant Medical$115
- plus $478 from 13 others
What the payments were for
- Travel & lodging$1,76224%
- Food & beverage$3,67949%
- Education$2,00727%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 43 | $3,703 |
| Micromed Inc | 2 | $2,007 |
| Pacira Therapeutics, Inc. | 28 | $512 |
| Bioventus LLC | 5 | $426 |
| Smith+Nephew | 3 | $208 |
| Pylant Medical | 1 | $115 |
| Arthrex | 1 | $108 |
| Dynasplint Systems Inc. | 1 | $65 |
| Cornerstone Medical Associates, Inc. | 1 | $59 |
| DJO, LLC | 2 | $53 |
| Orthofix Medical, Inc. | 1 | $38 |
| Zimmer Biomet | 1 | $31 |
| AbbVie | 1 | $27 |
| Johnson & Johnson | 1 | $17 |
| GSK | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Alafair Biosciences, Inc. | 1 | $15 |
| Avanos Medical | 1 | $15 |
| Fidia Pharma USA Inc. | 2 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AXSOS$951
- ACCULIF$783
- INFINITY$377
- STAR$257
- VARIAX$141
- Taylor Spatial Frame$140
- Exogen$113
- CAPITAL CONSUMABLES CONSUMABLES INSUFFLATION$108
- Exogen Ultrasound Bone Healing System$106
How this compares
$7,448 in reported general payments places this provider in the 65th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $167 |
| Ondansetron OdtOndansetron | 14 | $80 |
| Cephalexin | 14 | $75 |
| Meloxicam | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Santa Barbara
- Christopher ProctorSanta Barbara$1.1M
- Bradford HackArcadia$18.3M
- Robert GorabOrange$14.5M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Peter NewtonSan Diego$7M
- Nirav AminPlacentia$5.8M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.